Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation
Current Trends in Clinical & Medical Sciences Chen Hsiung Yeh* Circulogene Theranostics, Birmingham, USA Received Date: January 24, 2020 Published Date: January 29, 2020 Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation Click here to download full pdf High-throughput sequencing of circulating cell-free DNA (cfDNA) as liquid biopsy has revolutionized tumor genome…
CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury
$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel. BIRMINGHAM, Ala.–(BUSINESS WIRE)– CIRCULOGENE molecular diagnostics laboratory, a subcontractor to The Geneva Foundation (Geneva), which has been awarded a $1.5 million…
CIRCULOGENE Molecular Diagnostics Laboratory Receives College of American Pathologists (CAP) Accreditation
BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its molecular diagnostics laboratory has received College of American Pathologists (CAP) accreditation based on a recent on-site inspection as part of CAP’s Accreditation Programs. The CAP accreditation – and the Clinical Laboratory Improvement Amendments (CLIA) certification…